Xencor
XNCR
#5580
Rank
C$1.70 B
Marketcap
C$23.94
Share price
-4.63%
Change (1 day)
-33.22%
Change (1 year)

Earnings for Xencor (XNCR)

Earnings in 2025 (TTM): -C$0.2 Billion

According to Xencor's latest financial reports the company's current earnings are C$0.16 Billion. In 2024 the company made an earning of -C$0.34 Billion a decrease over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Xencor from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.2 Billion-41.81%
2024 -C$0.34 Billion101.73%
2023 -C$0.17 Billion120.95%
2022 -C$75.43 Million-165.97%
2021 C$0.11 B-219.18%
2020 -C$95.95 Million-355.02%
2019 C$37.62 M-138.61%
2018 -C$97.44 Million21.07%
2017 -C$80.48 Million-336.25%
2016 C$34.06 M-239.93%
2015 -C$24.35 Million7.12%
2014 -C$22.73 Million-72.75%
2013 -C$83.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-C$1.1 Billion 472.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-C$0.11 Billion-45.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.40 B-6,074.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.95 B-16,832.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.82 B-23,576.55%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.29 B-1,302.96%๐Ÿ‡บ๐Ÿ‡ธ USA